Joanna Szydelko
Overview
Explore the profile of Joanna Szydelko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Szydelko J, Czop M, Petniak A, Lenart-Lipinska M, Kocki J, Zapolski T, et al.
Cardiovasc Diabetol
. 2024 Jul;
23(1):278.
PMID: 39080630
Background: Type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD) are commonly coexisting clinical entities with still growing incidence worldwide. Recently, circulating microRNAs (miRNAs) have emerged as novel molecular...
2.
Lenart-Lipinska M, Luniewski M, Szydelko J, Matyjaszek-Matuszek B
J Clin Med
. 2023 Aug;
12(16).
PMID: 37629396
The prevalence of obesity, a disorder linked to numerous comorbidities and metabolic complications, has recently increased dramatically worldwide and is highly prevalent in men, even at a young age. Compared...
3.
Szydelko J, Matyjaszek-Matuszek B
Int J Mol Sci
. 2023 Jan;
24(1).
PMID: 36614057
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease with still growing incidence among adults and young people worldwide. Patients with T2DM are more susceptible to developing coronary artery...
4.
Szmygin H, Lenart-Lipinska M, Szydelko J, Wozniak S, Matyjaszek-Matuszek B
Ginekol Pol
. 2022 Aug;
93(8):665-669.
PMID: 35942720
Polycystic ovary syndrome (PCOS) is a common, heterogeneous endocrine disorder which effects 5-10% of reproductive-age women. Recently, an association between PCOS and an increased risk of developing metabolic disturbances, such...
5.
Szmygin H, Szydelko J, Matyjaszek-Matuszek B
J Clin Med
. 2022 Jun;
11(11).
PMID: 35683457
Objective: Prolactinomas are the most common type of functional, hormone-secreting pituitary adenomas that account for about 40% of total pituitary adenomas. Typical clinical presentations include loss of menstrual periods (amenorrhea)...
6.
Szydelko J, Szydelko-Gorzkowicz M, Matyjaszek-Matuszek B
J Clin Med
. 2021 Sep;
10(17).
PMID: 34501445
Acromegaly is a rare disease caused by overproduction of growth hormone (GH) by a pituitary adenoma, and consequently increased insulin-like growth factor 1 (IGF-1) concentration. The GH/IGF-1 axis and immune...
7.
Szmygin H, Szydelko J, Matyjaszek-Matuszek B
Endokrynol Pol
. 2021 Aug;
72(5):566-571.
PMID: 34378786
Arginine vasopressin (AVP), which is also called antidiuretic hormone (ADH), is a neurohormone synthetized from a pre-pro-hormone precursor in the supraoptic and paraventricular nuclei of the hypothalamus in response to...
8.
Szydelko J, Litwinczuk M, Szydelko M, Matyjaszek-Matuszek B
J Clin Med
. 2020 Sep;
9(10).
PMID: 32993174
Graves' orbitopathy (GO) is an autoimmune disease with a chronic inflammatory background. Smoking behavior is the main environmental factor responsible for the transition of this major extra thyroidal manifestation of...
9.
Sowa P, Goroszkiewicz K, Szydelko J, Chechlinska J, Pluta K, Domka W, et al.
Biomed Res Int
. 2018 Aug;
2018:2897827.
PMID: 30155477
Salivary gland tumours represent about 6% of head and neck neoplasms and about 0.5% of all malignancies in humans. Tumour growth and malignant transformation are complex processes involving various actions...